3MeenaA, NagarP. Pregnancy Outcome in Euthyroid Women with Anti-Thyroid Peroxidase Antibodies. Journal of obstetrics and gynaecology of India. 2016; 66: 160–165. DOI: 10.1007/s13224-014-0657-6
4AfreenE, HumayunM, SheikhA. Neurological spectrum of diseases associated with autoimmune thyroid disease: a case series to recognize diagnostically helpful signs. (P1.347). Neurology. 2018; 90: P1.347.
7de HolandaNC, de LimaDD, CavalcantiTB, LucenaCS, BandeiraF. Hashimoto’s encephalopathy: systematic review of the literature and an additional case. J Neuropsychiatry Clin Neurosci. 2011; 23: 384–390. DOI: 10.1176/jnp.23.4.jnp384
16JavaidA, HiltonDD. Persistent chorea as a manifestation of thyrotoxicosis. Postgraduate medical journal. 1988; 64: 789–790. DOI: 10.1136/pgmj.64.756.789
18Hernandez EchebarriaLE, SaizA, GrausF, et al. Detection of 14-3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy. Neurology. 2000; 54: 1539–1540. DOI: 10.1212/WNL.54.7.1539
24GuimaraesJ, SantosL, BugalhoP. Painful legs and moving toes syndrome associated with Hashimoto’s disease. European journal of neurology. 2007; 14: 343–345. DOI: 10.1111/j.1468-1331.2006.01513.x
26KuCR, ParkHJ, HongSJ, et al. A Case of Graves’ Disease Presenting with Chorea. J Korean Endocr Soc. 2008; 23: 342–346. DOI: 10.3803/jkes.2008.23.5.342
27YuJH, WengYM. Acute chorea as a presentation of Graves disease: case report and review. The American journal of emergency medicine. 2009; 27: 369.e361–369.e363. DOI: 10.1016/j.ajem.2008.05.031
28BrochL, AmthorKF. A 66-year-old woman with confusion, aphasia, and myoclonus. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2010; 130: 1041–1043. DOI: 10.4045/tidsskr.09.0697
31InoueK, KitamuraJ, YonedaM, ImamuraE, TokinobuH. Hashimoto’s encephalopathy presenting with micrographia as a typical feature of parkinsonism. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2012; 33: 395–397. DOI: 10.1007/s10072-011-0750-x
32RyanSA, KennedyC, HarringtonHJ. Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting as confusion, dysphasia, and myoclonus. Case reports in medicine. 2012; 2012: 782127. DOI: 10.1155/2012/782127
33ParkJ, KimJG, ParkSP, LeeHW. Asymmetric chorea as presenting symptom in Graves’ disease. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2012; 33: 343–345. DOI: 10.1007/s10072-011-0679-0
34NakavacharaP, SuppakruchaM, LikasitwattanakulS. Thyrotoxic periodic paralysis and chorea: two uncommon neuromuscular complications in an adolescent with newly diagnosed Graves disease. Int J Pediatr Endocrinol. 2013; 2013: P145–P145. DOI: 10.1186/1687-9856-2013-S1-P145
35KaminskaA, KaminskiM, NowaczewskaM, KsiazkiewiczB, JunikR. Chorea, convulsive seizures and cognitive impairment in a patient with autoimmune thyroid disease. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013; 34: 263–264. DOI: 10.1007/s10072-012-0990-4
36GhoreishiE, ShahidiGA, RohaniM, NabaviM, AghaeiM, AkhoundiFH. Palatal-Myoclonus as a Presentation of Hashimoto Encephalopathy: an interesting case report. Iranian journal of psychiatry. 2013; 8: 149–151.
37PhilipR, SaranS, GutchM, GuptaK. An unusual presentation of Hashimoto’s encephalopathy. Indian journal of endocrinology and metabolism. 2014; 18: 113–115. DOI: 10.4103/2230-8210.126589
41SharanA, SenguptaS, MukhopadhyayS, GhoshB. Hashimoto’s Encephalopathy Presenting with Chorea. The Journal of the Association of Physicians of India. 2015; 63: 83–84. DOI: 10.4103/0028-3886.170064
42SheetalSK, MathewR, PeethambaranB. Hashimoto’s encephalopathy as a treatable cause of corticobasal disease. Annals of Indian Academy of Neurology. 2016; 19: 285–286. DOI: 10.4103/0972-2327.176859
46KeshavarajA, AnpalaganJ. Reversible Orolingual Dyskinesia: An Unknown Presentation of Hashimoto’s Toxic Encephalopathy. Journal of Case Reports. 2018: 169–171. DOI: 10.17659/01.2018.0045
49DelhasseS, DeboveI, Arnold-KunzG, GhikaJA, ChabwineJN. Erratic movement disorders disclosing Graves’ disease and paralleling thyroid function but not autoantibody levels. The Journal of international medical research. 2019:300060518816873. DOI: 10.1177/0300060518816873
50ShreeR, MadhawG, ManchandaR, RadhakrishnanD, KumarN. Steroid responsive catatonia: A case of Hashimoto’s encephalopathy. Annals of Movement Disorders. 2020; 3: 51–55. DOI: 10.4103/AOMD.AOMD_32_19
51KlawansHL, Jr., ShenkerDM. Observations on the dopaminergic nature of hyperthyroid chorea. Journal of neural transmission. 1972; 33: 73–81. DOI: 10.1007/BF01244729
53LaiPH, TienRD, ChangMH, et al. Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR American journal of neuroradiology. 1996; 17: 1057–1064.
54ForchettiCM, KatsamakisG, GarronDC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997; 49: 623–626. DOI: 10.1212/WNL.49.2.623
55PariE, RinaldiF, PremiE, et al. A follow-up (1)(8)F-FDG brain PET study in a case of Hashimoto’s encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. J Neurol. 2014; 261: 663–667. DOI: 10.1007/s00415-013-7228-0
56GeorgeA, AbdurahmanP, JamesJ. Spastic paraparesis, abnormal muscle biopsy and positive antithyroid antibodies. The Journal of the Association of Physicians of India. 2007; 55: 585–586.
57BlanchinS, CoffinC, ViaderF, et al. Anti-thyroperoxidase antibodies from patients with Hashimoto’s encephalopathy bind to cerebellar astrocytes. Journal of neuroimmunology. 2007; 192: 13–20. DOI: 10.1016/j.jneuroim.2007.08.012
60SaravananP, DayanCM. Thyroid autoantibodies. Endocrinology and metabolism clinics of North America. 2001; 30: 315–337, viii. DOI: 10.1016/S0889-8529(05)70189-4
63CookMK, MalkinM, KarafinMS. The use of plasma exchange in Hashimoto’s encephalopathy: A case report and review of the literature. Journal of clinical apheresis. 2015; 30: 188–192. DOI: 10.1002/jca.21353